Complement synthesis and activation in the brain of SIV-infected monkeys

Barnum, 1995, Differential regulation of C3 gene expression in human astroglioma cells by interferon-γ and interleukin-1β, Neurosci. Lett., 197, 121, 10.1016/0304-3940(95)11923-K Brack-Werner, 1999, Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis, AIDS, 13, 1, 10.1097/00002030-199901140-00003 Budka, 1991, Neuropathology of human immunodeficiency virus infection, Brain Pathol., 1, 163, 10.1111/j.1750-3639.1991.tb00656.x Cheingsong-Popov, 1990, Antibodies to HIV-1 nef (p27): prevalence, significance and relationship to seroconversion, AIDS Res. Hum. Retrovir., 9, 1099, 10.1089/aid.1990.6.1099 Dashiell, 1997, Dibutyryl cyclic AMP and inflammatory cytokines mediate C3 expression in Schwann cells, Glia, 20, 308, 10.1002/(SICI)1098-1136(199708)20:4<308::AID-GLIA4>3.0.CO;2-1 Eikelbloom, 1989, Complement activation in amyloid plaques in Alzheimer's dementia, Arch. Cell. Pathol., 56, 259 Fabry, 1994, Nervous tissue as an immune compartment: the dialect of the immune response in the CNS, Immunol. Today, 15, 218, 10.1016/0167-5699(94)90247-X Gamalei, 1998, Mechanisms of hyperpolarization of plasma membrane of macrophages and astrocytes during activation, Tsitologiia, 40, 773 Gasque, 2000, Complement components in the innate immune system in health and disease in the CNS, Immunopharmacology, 49, 171, 10.1016/S0162-3109(00)80302-1 Hailer, 1998, Astrocytic factors deactivate antigen presenting cells that invade the central nervous system, Brain Pathol., 8, 459, 10.1111/j.1750-3639.1998.tb00168.x Heese, 1998, Inflammatory signals induce neurotrophin expression in human microglial cells, J. Neurochem., 70, 699, 10.1046/j.1471-4159.1998.70020699.x Hosokawa, 2003, Expression of complement messenger RNAs and proteins by human oligodendroglial cells, Glia, 42, 417, 10.1002/glia.10234 Hsu, 1981, Use of avidin–biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures, J. Histochem. Cytochem., 29, 577, 10.1177/29.4.6166661 Huang, 1999, Neuronal protection in stroke by an sLEx-glycosylated complement inhibitory protein, Science, 285, 595, 10.1126/science.285.5427.595 Jongen, 2000, Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system, Acta Neurol. Scand., 101, 116, 10.1034/j.1600-0404.2000.101002116.x Moller, 1997, Mechanisms of C5a and C3a complement fragment-induced [Ca2+]I signalling in mouse microglia, J. Neurosci., 17, 615, 10.1523/JNEUROSCI.17-02-00615.1997 Morgan, 1993, 353 Morgan, 1996, Expression of complement in the brain: role in health and disease, Immunol. Today, 17, 461, 10.1016/0167-5699(96)20028-F Nolte, 1996, C5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton, Neuroscience, 73, 1091, 10.1016/0306-4522(96)00106-6 Osaka, 1999, Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration, Neuroscience, 88, 1073, 10.1016/S0306-4522(98)00372-8 Osaka, 1999, Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity, J. Cell. Biochem., 73, 303, 10.1002/(SICI)1097-4644(19990601)73:3<303::AID-JCB2>3.0.CO;2-2 Rogers, 1992, Complement activation by β-amyloid in Alzheimer disease, Proc. Natl. Acad. Sci. U. S. A., 89, 10016, 10.1073/pnas.89.21.10016 Rus, 1992, Induction of C3 expression in astrocytes is regulated by cytokines and Newcastle disease virus, J. Immunol., 148, 928, 10.4049/jimmunol.148.3.928 Sayah, 1999, Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression, J. Neurochem., 72, 2426, 10.1046/j.1471-4159.1999.0722426.x Sheerin, 1996, TNF-α regulation of C3 gene expression and protein biosynthesis in rat glomerular endothelial cells, Kidney Int., 51, 703, 10.1038/ki.1997.101 Singhrao, 2000, Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis, Am. J. Pathol., 157, 905, 10.1016/S0002-9440(10)64604-4 Speth, 1997, Complement receptors in HIV infection, Immunol. Rev., 159, 49, 10.1111/j.1600-065X.1997.tb01006.x Speth, 1999, The complement system: pathophysiology and clinical relevance, Wien. Klin. Wochenschr., 111/10, 378 Speth, 2001, Human immunodeficiency virus type 1 induced expression of complement factors in human astrocytes, J. Virol., 75, 2604, 10.1128/JVI.75.6.2604-2516.2001 Speth, 2002, Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons, J. Virol., 76, 3179, 10.1128/JVI.76.7.3179-3188.2002 Speth, 2002, Neuroinvasion by pathogens: a key role of the complement system, Mol. Immunol., 38, 669, 10.1016/S0161-5890(01)00104-3 van Beek, 2003, Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection, Ann. N. Y. Acad. Sci., 992, 56, 10.1111/j.1749-6632.2003.tb03138.x Veerhuis, 1996, Early complement components in Alzheimer's disease brains, Acta Neuropathol., 91, 53, 10.1007/s004019570001 Xiao, 1998, Astrocytes induce hyporesponses of myelin basic protein-reactive T and B cell function, J. Neuroimmunol., 89, 113, 10.1016/S0165-5728(98)00123-4 Yasojima, 1999, Up-regulated production and activation of the complement system in Alzheimer's disease brain, Am. J. Pathol., 154, 927, 10.1016/S0002-9440(10)65340-0